{"count": 1, "results": [{"_id": "27800648", "pmid": 27800648, "title": "Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice.", "journal": "Diabetes Obes Metab", "authors": ["Mitchell PL", "Nachbar R", "Lachance D", "St-Pierre P", "Trottier J", "Barbier O", "Marette A"], "date": "2017-03-01T00:00:00Z", "doi": "10.1111/dom.12818", "meta_date_publication": "2017 Mar", "meta_volume": "19", "meta_issue": "3", "meta_pages": "313-319", "score": 50079.285, "text_hl": "We next tested the long-term glucoregulatory effect of oral @<m>CHEMICAL_TP_113</m> @CHEMICAL_MESH:C000624431 @@@TP-113@@@ in @<m>DISEASE_Obesity</m> @DISEASE_MESH:D009765 @@@obese diabetic@@@ db/db @SPECIES_10090 @@@mice@@@ and compared its effect to an equivalent dose of @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Mitchell PL, Nachbar R, Lachance D, St-Pierre P, Trottier J, Barbier O, Marette A. Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice. Diabetes Obes Metab. 2017 Mar;19(3):313-319. PMID: 27800648", "BibTeX": "@article{27800648, title={Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice.}, author={Mitchell PL and Nachbar R and Lachance D and St-Pierre P and Trottier J and Barbier O and Marette A}, journal={Diabetes Obes Metab}, volume={19}, number={3}, pages={313-319}}"}}]}